News archive

Home News archivePage 14

Protection of trade secrets in the life sciences field

May 21, 2024 By Editorial Staff In Events
In the landscape of biotechnology, the process of technology transfer plays a key role in converting laboratory discoveries into market solutions. Through the formalization of license agreements and the establishment of collaborations and alliances, the effective dissemination of patented technologi...
Read More

Rights related to inventions: legislative novelties in Italian laws

May 21, 2024 By Editorial Staff In Events
In the field of biotechnology, technology transfer represents a cornerstone for the transition of scientific discoveries from the laboratory to the commercial context. Through the negotiation of license agreements, collaborations, and partnerships, it is possible to facilitate the sharing of patente...
Read More

Why gene therapies must go virus-free

May 21, 2024 By Editorial Staff In Biology, Pharmacology, R&D, Technologies
Gene therapies have made spectacular progress in delivering new cures for previously intractable disease, where virus vectors-particularly those based on adeno-associated virus (AAV) and lentiviruses, have dominated this first wave of gene therapeutics. Nevertheless, they remain the world’s most e...
Read More

Health Innovation Global Forum

May 01, 2024 By Editorial Staff In Events
Health Innovation Global Forum Edra Ittbiomed
MIND, 9 MAY 2024 – Auditorium Human Technopole – Viale Rita Levi-Montalcini, 1, 20157 The availability of new technologies in the study of biological mechanisms has opened up new perspectives and deepened the understanding of biological processes, a better definition of morbid conditions...
Read More

Unprecedented blood biomarker enables ALS drug approval

April 29, 2024 By Editorial Staff In Biology, R&D
Biogen’s Qalsody (tofersen) has been approved by the US Food and Drug Administration (FDA) for treating a rare form of amyotrophic lateral sclerosis (ALS). This is a good news for the small number of patients, affected by a genetically defined form of ALS, expected to access the antisense drug. Mo...
Read More